CARIPRAZINE

CARIPRAZINE was reported 9636 times

CARIPRAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL EPIBLEPHARON 3 0.7500
1 AFFECTIVE AMBIVALENCE 3 0.3333
2 PSEUDOHALLUCINATION 6 0.1935
3 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 8 0.1194
4 CIRCULATORY FAILURE NEONATAL 6 0.1017
5 TONGUE THRUST 8 0.0889
6 MANIC SYMPTOM 14 0.0833
7 REVERSIBLE SPLENIAL LESION SYNDROME 4 0.0625
8 COMPULSIVE CHEEK BITING 3 0.0588
9 AMNIOTIC FLUID VOLUME INCREASED 8 0.0506
10 HOMOSEXUALITY 3 0.0492
11 HYPERRESPONSIVE TO STIMULI 3 0.0476
12 NEGLECT OF PERSONAL APPEARANCE 11 0.0453
13 ANTICHOLINERGIC EFFECT 3 0.0400
14 SPASMODIC DYSPHONIA 12 0.0396
15 RED BLOOD CELL SEDIMENTATION RATE DECREASED 10 0.0383
16 AKATHISIA 434 0.0318
17 OBSESSIVE-COMPULSIVE SYMPTOM 11 0.0298
18 DELUSION OF GRANDEUR 12 0.0267
19 OCULOGYRIC CRISIS 53 0.0247
20 HALLUCINATION, TACTILE 14 0.0210
21 ORTHOSTATIC HYPERTENSION 12 0.0206
22 LACTATION DISORDER 10 0.0205
23 ACTIVATION SYNDROME 7 0.0202
24 SOCIAL ANXIETY DISORDER 13 0.0198
25 BLUNTED AFFECT 13 0.0176
26 ANTEROGRADE AMNESIA 10 0.0167
27 BIPOLAR II DISORDER 6 0.0167
28 TONGUE MOVEMENT DISTURBANCE 14 0.0164
29 LIPID METABOLISM DISORDER 6 0.0156
30 LACTATION INSUFFICIENCY 3 0.0145
31 TARDIVE DYSKINESIA 392 0.0139
32 VITAMIN D ABNORMAL 5 0.0122
33 PROTRUSION TONGUE 7 0.0120
34 HYPERSEXUALITY 21 0.0115
35 CONFABULATION 3 0.0113
36 SCHIZOAFFECTIVE DISORDER 20 0.0112
37 PLEUROTHOTONUS 10 0.0111
38 BLOOD PROLACTIN INCREASED 50 0.0106
39 DISTRIBUTIVE SHOCK 24 0.0106
40 GAMBLING DISORDER 28 0.0104
41 MANIA 169 0.0103
42 PSYCHOTIC SYMPTOM 20 0.0097
43 GAMBLING 11 0.0094
44 PARKINSONISM 91 0.0093
45 HYPOMANIA 34 0.0092
46 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 4 0.0090
47 DRUG DOSE TITRATION NOT PERFORMED 16 0.0087
48 ABULIA 8 0.0086
49 SLEEP-RELATED EATING DISORDER 8 0.0085
50 OROMANDIBULAR DYSTONIA 6 0.0082
51 GRANDIOSITY 3 0.0082
52 DRUG-DISEASE INTERACTION 6 0.0082
53 BLOOD PROLACTIN ABNORMAL 7 0.0081
54 FACIAL SPASM 9 0.0080
55 METABOLIC SYNDROME 13 0.0079
56 COMPULSIVE SHOPPING 16 0.0078
57 CEREBELLAR STROKE 3 0.0077
58 PERSECUTORY DELUSION 19 0.0076
59 EXTRAPYRAMIDAL DISORDER 188 0.0076
60 MORNING SICKNESS 4 0.0073
61 BIPOLAR I DISORDER 16 0.0073
62 PRODUCT ADMINISTRATION INTERRUPTED 57 0.0073
63 BRUXISM 39 0.0072
64 HALLUCINATION, AUDITORY 113 0.0071
65 FLAT AFFECT 16 0.0069
66 HALLUCINATION, OLFACTORY 3 0.0069
67 LIBIDO INCREASED 14 0.0069
68 REDUCED FACIAL EXPRESSION 7 0.0069
69 BIPOLAR DISORDER 74 0.0068
70 DROOLING 47 0.0068
71 AMBLYOPIA 4 0.0068
72 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9 0.0067
73 TACHYPHRENIA 23 0.0066
74 QRS AXIS ABNORMAL 5 0.0065
75 SITTING DISABILITY 4 0.0065
76 PSYCHOGENIC SEIZURE 6 0.0064
77 IMPULSE-CONTROL DISORDER 13 0.0063
78 COMPULSIVE SEXUAL BEHAVIOUR 5 0.0062
79 SLOW SPEECH 15 0.0062
80 SUSPICIOUSNESS 4 0.0057
81 RESTLESSNESS 208 0.0057
82 ANTIPSYCHOTIC DRUG LEVEL DECREASED 3 0.0056
83 DISSOCIATION 43 0.0056
84 BINGE EATING 6 0.0056
85 DISSOCIATIVE DISORDER 4 0.0055
86 ESCHAR 4 0.0055
87 BLOOD UREA ABNORMAL 5 0.0053
88 INTENTION TREMOR 3 0.0053
89 NEUROLEPTIC MALIGNANT SYNDROME 61 0.0051
90 ALCOHOL ABUSE 13 0.0049
91 DEPRESSIVE SYMPTOM 17 0.0048
92 SEDATION 126 0.0048
93 SELF-INJURIOUS IDEATION 20 0.0048
94 GENERALISED ANXIETY DISORDER 7 0.0048
95 SEDATION COMPLICATION 12 0.0047
96 MENTAL FATIGUE 7 0.0047
97 PATIENT DISSATISFACTION WITH TREATMENT 9 0.0047
98 DRUG TITRATION ERROR 12 0.0046
99 SOMATIC SYMPTOM DISORDER 5 0.0046
100 SOLILOQUY 4 0.0046
101 PSYCHIATRIC DECOMPENSATION 9 0.0046
102 PILOERECTION 5 0.0046
103 EMOTIONAL POVERTY 8 0.0046
104 IMPULSIVE BEHAVIOUR 17 0.0045
105 TERMINAL INSOMNIA 8 0.0045
106 COMPULSIONS 3 0.0045
107 STRABISMUS 13 0.0044
108 DELUSION 68 0.0044
109 OBSESSIVE-COMPULSIVE DISORDER 35 0.0044
110 DISTRACTIBILITY 5 0.0043
111 HALLUCINATIONS, MIXED 18 0.0043
112 SCHIZOPHRENIA 52 0.0043
113 INTRUSIVE THOUGHTS 5 0.0042
114 NARCOLEPSY 8 0.0042
115 DEREALISATION 9 0.0042
116 GASTRIC BYPASS 9 0.0041
117 SOMNAMBULISM 27 0.0041
118 SLEEP PARALYSIS 6 0.0041
119 DELUSIONAL DISORDER, UNSPECIFIED TYPE 3 0.0040
120 HYPERPROLACTINAEMIA 26 0.0040
121 AMPHETAMINES POSITIVE 3 0.0040
122 BREAST DISCHARGE 7 0.0040
123 DYSKINESIA 161 0.0040
124 VIOLENCE-RELATED SYMPTOM 6 0.0039
125 SLOW RESPONSE TO STIMULI 5 0.0039
126 ATTENTION DEFICIT HYPERACTIVITY DISORDER 16 0.0038
127 DISORGANISED SPEECH 7 0.0038
128 HYPERPHAGIA 15 0.0038
129 PSYCHOTIC DISORDER 111 0.0038
130 HEPATITIS VIRAL 3 0.0037
131 MAJOR DEPRESSION 27 0.0037
132 SUICIDAL IDEATION 337 0.0037
133 TRISMUS 19 0.0037
134 TIC 20 0.0037
135 ALTERED VISUAL DEPTH PERCEPTION 3 0.0037
136 RESUSCITATION 6 0.0036
137 PARANOIA 62 0.0036
138 TEMPERATURE REGULATION DISORDER 8 0.0036
139 DYSTONIA 69 0.0036
140 ANTIPSYCHOTIC DRUG LEVEL INCREASED 10 0.0035
141 METABOLIC SURGERY 4 0.0035
142 MYOCARDITIS 39 0.0034
143 BRAIN FOG 51 0.0033
144 INCREASED APPETITE 62 0.0032
145 BRADYKINESIA 19 0.0032
146 RESTLESS LEGS SYNDROME 56 0.0031
147 MUSCLE TWITCHING 70 0.0030
148 BLOOD CALCIUM ABNORMAL 5 0.0030
149 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13 0.0030
150 POST-TRAUMATIC STRESS DISORDER 20 0.0030
151 GALACTORRHOEA 19 0.0030
152 ANORGASMIA 8 0.0029
153 INTESTINAL ISCHAEMIA 16 0.0029
154 SUDDEN ONSET OF SLEEP 4 0.0029
155 PHYSICAL ASSAULT 6 0.0029
156 SEROTONIN SYNDROME 55 0.0029
157 COGWHEEL RIGIDITY 3 0.0029
158 SLEEP DEFICIT 6 0.0028
159 SALIVARY HYPERSECRETION 28 0.0028
160 EXPOSURE VIA BREAST MILK 11 0.0028
161 METABOLIC DISORDER 16 0.0028
162 JUDGEMENT IMPAIRED 4 0.0028
163 CLAUSTROPHOBIA 3 0.0027
164 ENURESIS 11 0.0027
165 PRE-EXISTING CONDITION IMPROVED 17 0.0027
166 EXCESSIVE EYE BLINKING 4 0.0027
167 HICCUPS 22 0.0027
168 DRUG EFFECT VARIABLE 3 0.0026
169 EYE MOVEMENT DISORDER 18 0.0026
170 CARBON DIOXIDE DECREASED 3 0.0026
171 BEHAVIOUR DISORDER 14 0.0026
172 MORBID THOUGHTS 3 0.0026
173 ORTHOSTATIC HYPOTENSION 44 0.0025
174 INTRACRANIAL PRESSURE INCREASED 14 0.0025
175 MUSCLE RIGIDITY 30 0.0025
176 PANIC REACTION 18 0.0025
177 STARING 6 0.0025
178 HYPERVOLAEMIA 12 0.0024
179 ACUTE PSYCHOSIS 6 0.0024
180 AKINESIA 5 0.0024
181 NEGATIVE THOUGHTS 7 0.0024
182 SLEEP TERROR 10 0.0024
183 GLUCOSE URINE PRESENT 3 0.0024
184 HALLUCINATION, VISUAL 49 0.0023
185 OLIGOMENORRHOEA 5 0.0023
186 AFFECTIVE DISORDER 18 0.0023
187 DYSPHEMIA 10 0.0023
188 TREMOR 378 0.0023
189 HYPOVITAMINOSIS 3 0.0023
190 TALIPES 7 0.0023
191 WEIGHT INCREASED 501 0.0022
192 BLEPHAROSPASM 14 0.0022
193 BODY MASS INDEX INCREASED 3 0.0022
194 DECREASED INTEREST 13 0.0022
195 PREGNANCY 44 0.0022
196 AGORAPHOBIA 3 0.0022
197 HEAD TITUBATION 3 0.0022
198 ENDOTRACHEAL INTUBATION 6 0.0021
199 MAST CELL ACTIVATION SYNDROME 3 0.0021
200 IMPAIRED DRIVING ABILITY 24 0.0021
201 GUN SHOT WOUND 4 0.0021
202 VITAMIN D DECREASED 18 0.0021
203 THINKING ABNORMAL 39 0.0021
204 COMA SCALE ABNORMAL 6 0.0021
205 OCULAR HYPERTENSION 4 0.0021
206 IMPAIRED GASTRIC EMPTYING 28 0.0021
207 OVERWEIGHT 11 0.0020
208 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
209 MUSCLE TIGHTNESS 33 0.0020
210 ENERGY INCREASED 12 0.0020
211 PANIC ATTACK 74 0.0020
212 EJACULATION FAILURE 4 0.0020
213 BRADYPHRENIA 13 0.0020
214 INTELLECTUAL DISABILITY 3 0.0020
215 TROPONIN INCREASED 15 0.0020
216 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
217 EUPHORIC MOOD 20 0.0020
218 IMPAIRED SELF-CARE 4 0.0019
219 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
220 PERFORMANCE STATUS DECREASED 9 0.0019
221 INSULIN RESISTANCE 4 0.0019
222 BODY TEMPERATURE FLUCTUATION 4 0.0019
223 APATHY 28 0.0019
224 FORMICATION 13 0.0019
225 BLOOD TESTOSTERONE INCREASED 4 0.0019
226 MENTAL IMPAIRMENT 45 0.0019
227 INTENTIONAL SELF-INJURY 37 0.0018
228 AGITATION 133 0.0018
229 PANIC DISORDER 7 0.0018
230 MYDRIASIS 23 0.0018
231 SUICIDE ATTEMPT 108 0.0018
232 ANGER 60 0.0018
233 BLOOD CHLORIDE INCREASED 3 0.0017
234 FEELING JITTERY 33 0.0017
235 INFUSION SITE DISCHARGE 3 0.0017
236 SUICIDAL BEHAVIOUR 7 0.0017
237 WITHDRAWAL SYNDROME 69 0.0016
238 SHOULDER OPERATION 7 0.0016
239 FEELING DRUNK 12 0.0016
240 HYPERSOMNIA 46 0.0016
241 HALLUCINATION 120 0.0016
242 HOSTILITY 4 0.0016
243 AGGRESSION 78 0.0016
244 TREATMENT NONCOMPLIANCE 85 0.0016
245 REHABILITATION THERAPY 6 0.0015
246 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
247 SEXUAL DYSFUNCTION 18 0.0015
248 PSYCHOMOTOR SKILLS IMPAIRED 4 0.0015
249 FACIAL PARALYSIS 13 0.0015
250 CATATONIA 8 0.0015
251 NYSTAGMUS 8 0.0015
252 IMPAIRED WORK ABILITY 32 0.0015
253 CRYING 54 0.0015
254 AMENORRHOEA 26 0.0015
255 HOMICIDAL IDEATION 6 0.0015
256 SINUS TACHYCARDIA 21 0.0015
257 GESTATIONAL DIABETES 7 0.0015
258 PRODUCT USE COMPLAINT 23 0.0015
259 AFFECT LABILITY 14 0.0015
260 DEPRESSION SUICIDAL 5 0.0014
261 HUNGER 20 0.0014
262 IRRITABILITY 86 0.0014
263 ELECTRIC SHOCK SENSATION 4 0.0014
264 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
265 FOOT OPERATION 7 0.0014
266 EJACULATION DISORDER 4 0.0014
267 SMALL FOR DATES BABY 7 0.0014
268 VOMITING PROJECTILE 4 0.0014
269 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
270 ANXIETY 392 0.0014
271 CERVICAL DYSPLASIA 3 0.0014
272 INSURANCE ISSUE 21 0.0014
273 SLUGGISHNESS 14 0.0014
274 PSYCHIATRIC SYMPTOM 10 0.0014
275 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
276 MENTAL DISORDER 58 0.0013
277 INSOMNIA 354 0.0013
278 LOSS OF EMPLOYMENT 4 0.0013
279 INCONTINENCE 14 0.0013
280 DRUG INTERACTION 210 0.0013
281 SNORING 5 0.0013
282 EMERGENCY CARE 4 0.0013
283 DISABILITY 26 0.0013
284 SLEEP APNOEA SYNDROME 25 0.0013
285 DEPRESSED MOOD 69 0.0013
286 DEPRESSION 296 0.0013
287 NIGHTMARE 45 0.0013
288 CONCUSSION 10 0.0013
289 THERAPEUTIC PRODUCT EFFECT DECREASED 57 0.0013
290 EATING DISORDER 27 0.0013
291 INITIAL INSOMNIA 13 0.0013
292 SOMNOLENCE 253 0.0013
293 EXPOSURE TO TOXIC AGENT 4 0.0012
294 FRUSTRATION TOLERANCE DECREASED 10 0.0012
295 CARDIAC FLUTTER 8 0.0012
296 OFF LABEL USE 1083 0.0012
297 MIDDLE INSOMNIA 23 0.0012
298 BRONCHITIS CHRONIC 3 0.0012
299 PHARYNGEAL SWELLING 12 0.0012
300 ENCEPHALOPATHY 30 0.0012
301 SPEECH DISORDER 64 0.0012
302 CARTILAGE INJURY 3 0.0012
303 LISTLESS 4 0.0012
304 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 58 0.0012
305 LIVE BIRTH 10 0.0012
306 ERECTION INCREASED 5 0.0012
307 ENDODONTIC PROCEDURE 3 0.0012
308 PETIT MAL EPILEPSY 6 0.0012
309 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
310 ALCOHOLISM 5 0.0012
311 MENOPAUSE 3 0.0012
312 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
313 FOOD CRAVING 6 0.0011
314 MOOD ALTERED 31 0.0011
315 LOGORRHOEA 4 0.0011
316 SEASONAL ALLERGY 16 0.0011
317 OBESITY 18 0.0011
318 DRUG RESISTANCE 29 0.0011
319 FIBRIN D DIMER INCREASED 4 0.0011
320 INTENTIONAL OVERDOSE 72 0.0011
321 MOVEMENT DISORDER 36 0.0011
322 SLEEP DISORDER 79 0.0011
323 ABNORMAL BEHAVIOUR 44 0.0011
324 CHONDROPATHY 3 0.0011
325 INABILITY TO AFFORD MEDICATION 11 0.0011
326 SPONDYLITIS 4 0.0011
327 HAEMOGLOBIN INCREASED 5 0.0011
328 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
329 THERAPY PARTIAL RESPONDER 17 0.0011
330 MUSCULOSKELETAL STIFFNESS 95 0.0011
331 DRUG SCREEN FALSE POSITIVE 3 0.0011
332 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 77 0.0011
333 ARTHROPOD BITE 8 0.0011
334 INTERMENSTRUAL BLEEDING 6 0.0011
335 FEELING OF DESPAIR 5 0.0011
336 POOR QUALITY SLEEP 23 0.0011
337 SENSATION OF FOREIGN BODY 9 0.0011
338 DELIRIUM 37 0.0011
339 ANHEDONIA 28 0.0011
340 IMPAIRED QUALITY OF LIFE 15 0.0010
341 LIMB OPERATION 5 0.0010
342 FEAR 28 0.0010
343 SEIZURE 120 0.0010
344 HYPERTONIC BLADDER 3 0.0010
345 FOOD ALLERGY 8 0.0010
346 FEEDING DISORDER 21 0.0010
347 RASH VESICULAR 5 0.0010
348 DISTURBANCE IN ATTENTION 55 0.0010
349 INTENTIONAL DOSE OMISSION 29 0.0010
350 HOSPICE CARE 10 0.0010
351 INFUSION SITE REACTION 3 0.0010
352 HYPERNATRAEMIA 5 0.0010
353 HEAVY MENSTRUAL BLEEDING 9 0.0010
354 URINARY RETENTION 33 0.0010
355 MATERNAL EXPOSURE DURING BREAST FEEDING 4 0.0010
356 DYSLIPIDAEMIA 5 0.0010
357 SELF-MEDICATION 4 0.0010
358 SOCIAL PROBLEM 4 0.0010
359 MATERNAL EXPOSURE DURING PREGNANCY 86 0.0010
360 FEELING ABNORMAL 231 0.0010
361 COGNITIVE DISORDER 45 0.0010
362 MALABSORPTION 5 0.0010
363 VISION BLURRED 131 0.0010
364 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
365 BLADDER PAIN 3 0.0009
366 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
367 THERAPEUTIC RESPONSE UNEXPECTED 42 0.0009
368 DYSARTHRIA 35 0.0009
369 PHARYNGITIS STREPTOCOCCAL 10 0.0009
370 LYMPHOCYTE COUNT INCREASED 3 0.0009
371 THERAPY CHANGE 9 0.0009
372 ADVERSE DRUG REACTION 82 0.0009
373 NONSPECIFIC REACTION 5 0.0009
374 HYPOTONIA 9 0.0009
375 COMPLETED SUICIDE 75 0.0009
376 RESPIRATORY DEPRESSION 11 0.0009
377 SPINAL OPERATION 11 0.0009
378 MULTIPLE ALLERGIES 7 0.0009
379 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
380 REBOUND EFFECT 10 0.0009
381 DISORIENTATION 35 0.0009
382 THERAPY INTERRUPTED 63 0.0009
383 HYPERVENTILATION 5 0.0009
384 ARTHRITIS INFECTIVE 4 0.0009
385 HYPERREFLEXIA 3 0.0009
386 THERAPY CESSATION 44 0.0009
387 HYPERHIDROSIS 110 0.0009
388 SUSPECTED SUICIDE 4 0.0009
389 PHOTOPHOBIA 16 0.0008
390 MOOD SWINGS 27 0.0008
391 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
392 DEVICE PLACEMENT ISSUE 3 0.0008
393 FACIAL BONES FRACTURE 3 0.0008
394 ABNORMAL DREAMS 23 0.0008
395 TACHYCARDIA 74 0.0008
396 SWOLLEN TONGUE 26 0.0008
397 DYSSTASIA 24 0.0008
398 ERECTILE DYSFUNCTION 21 0.0008
399 MIGRAINE 78 0.0008
400 PANCREATIC DISORDER 4 0.0008
401 DYSPHAGIA 77 0.0008
402 CEREBRAL DISORDER 6 0.0008
403 EMOTIONAL DISORDER 25 0.0008
404 HYPERACUSIS 3 0.0008
405 APHASIA 24 0.0008
406 HYPOTHERMIA 8 0.0008
407 SCREAMING 5 0.0008
408 ILLNESS 79 0.0008
409 TINNITUS 35 0.0008
410 PNEUMONIA ASPIRATION 19 0.0008
411 KNEE ARTHROPLASTY 16 0.0008
412 DRUG SCREEN POSITIVE 6 0.0008
413 HYPOKINESIA 11 0.0008
414 FUNGAL SKIN INFECTION 3 0.0007
415 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
416 SKIN LACERATION 8 0.0007
417 ECONOMIC PROBLEM 11 0.0007
418 JOINT STIFFNESS 19 0.0007
419 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
420 AMNESIA 47 0.0007
421 HYPERTRANSAMINASAEMIA 5 0.0007
422 AUTOIMMUNE DISORDER 7 0.0007
423 PRODUCT LEAKAGE 4 0.0007
424 URINARY INCONTINENCE 21 0.0007
425 MICTURITION URGENCY 8 0.0007
426 MEMORY IMPAIRMENT 96 0.0007
427 HYPERTONIA 4 0.0007
428 POLLAKIURIA 29 0.0007
429 HORDEOLUM 3 0.0007
430 CONFUSIONAL STATE 112 0.0007
431 VISUAL FIELD DEFECT 5 0.0007
432 IMMOBILE 3 0.0007
433 FOOT FRACTURE 13 0.0007
434 HYPERTRIGLYCERIDAEMIA 4 0.0007
435 TOOTH INFECTION 9 0.0007
436 LIGAMENT RUPTURE 3 0.0007
437 LYMPHOCYTE COUNT DECREASED 12 0.0007
438 BLINDNESS TRANSIENT 5 0.0007
439 HYPERBILIRUBINAEMIA 7 0.0007
440 MUSCLE SPASMS 124 0.0007
441 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37 0.0007
442 ACCIDENT 8 0.0007
443 LOSS OF LIBIDO 6 0.0007
444 GENERAL SYMPTOM 5 0.0007
445 ANAL INCONTINENCE 6 0.0007
446 SURGERY 39 0.0007
447 BREAST TENDERNESS 5 0.0007
448 LIP DRY 6 0.0007
449 FIBROMYALGIA 16 0.0007
450 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
451 TENSION 4 0.0007
452 HYPERTHERMIA 5 0.0007
453 EPILEPSY 20 0.0007
454 BOWEL MOVEMENT IRREGULARITY 5 0.0007
455 EYE OPERATION 3 0.0007
456 LIMB DISCOMFORT 20 0.0006
457 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
458 ROAD TRAFFIC ACCIDENT 27 0.0006
459 GASTRITIS EROSIVE 3 0.0006
460 INFUSION SITE SWELLING 4 0.0006
461 TOOTH FRACTURE 7 0.0006
462 BLOOD POTASSIUM DECREASED 19 0.0006
463 THERAPEUTIC RESPONSE CHANGED 4 0.0006
464 FURUNCLE 5 0.0006
465 NERVE INJURY 7 0.0006
466 ENDOMETRIOSIS 3 0.0006
467 PRODUCT USE IN UNAPPROVED INDICATION 154 0.0006
468 HEAD DISCOMFORT 11 0.0006
469 DIZZINESS POSTURAL 6 0.0006
470 INCOHERENT 4 0.0006
471 PALPITATIONS 72 0.0006
472 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
473 KNEE OPERATION 6 0.0006
474 GASTROENTERITIS VIRAL 11 0.0006
475 UNEVALUABLE EVENT 46 0.0006
476 DRY MOUTH 49 0.0006
477 MENSTRUAL DISORDER 5 0.0006
478 APPETITE DISORDER 4 0.0006
479 EOSINOPHIL COUNT INCREASED 5 0.0006
480 COVID-19 PNEUMONIA 7 0.0006
481 DYSPHORIA 3 0.0006
482 DRY THROAT 6 0.0006
483 BALANCE DISORDER 51 0.0006
484 LIMB INJURY 16 0.0006
485 MOTOR DYSFUNCTION 6 0.0006
486 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
487 STEVENS-JOHNSON SYNDROME 13 0.0006
488 CEREBRAL ISCHAEMIA 3 0.0006
489 TEMPERATURE INTOLERANCE 6 0.0006
490 DIZZINESS 290 0.0006
491 RESPIRATION ABNORMAL 4 0.0006
492 RESPIRATORY DISTRESS 16 0.0006
493 BLOOD MAGNESIUM DECREASED 5 0.0006
494 HOSPITALISATION 89 0.0006
495 MUSCULOSKELETAL DISORDER 11 0.0006
496 HYSTERECTOMY 5 0.0006
497 THERAPEUTIC RESPONSE SHORTENED 19 0.0006
498 HEPATIC ENZYME INCREASED 39 0.0006
499 PRODUCT AVAILABILITY ISSUE 13 0.0006
500 JOINT DISLOCATION 6 0.0006
501 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
502 THERMAL BURN 4 0.0006
503 ILEUS 7 0.0006
504 PRODUCT SUPPLY ISSUE 4 0.0006
505 DECREASED ACTIVITY 6 0.0006
506 HEART RATE INCREASED 55 0.0006
507 TONGUE DISORDER 4 0.0006
508 HEPATIC CYTOLYSIS 7 0.0005
509 CHOKING SENSATION 3 0.0005
510 DENTAL CARIES 6 0.0005
511 BLOOD GLUCOSE ABNORMAL 10 0.0005
512 MENTAL STATUS CHANGES 15 0.0005
513 LOSS OF CONSCIOUSNESS 69 0.0005
514 NERVOUSNESS 28 0.0005
515 RIB FRACTURE 11 0.0005
516 TYPE 2 DIABETES MELLITUS 18 0.0005
517 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
518 MUSCULAR WEAKNESS 60 0.0005
519 HYPOAESTHESIA 79 0.0005
520 CHOLECYSTECTOMY 6 0.0005
521 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
522 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
523 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
524 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
525 LIVER FUNCTION TEST INCREASED 11 0.0005
526 CONSTIPATION 111 0.0005
527 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
528 LETHARGY 29 0.0005
529 THIRST 9 0.0005
530 ORAL DISCOMFORT 7 0.0005
531 BLADDER DISORDER 5 0.0005
532 INTENTIONAL PRODUCT MISUSE 44 0.0005
533 COORDINATION ABNORMAL 7 0.0005
534 BRAIN INJURY 5 0.0005
535 DRUG INTOLERANCE 48 0.0005
536 NIGHT SWEATS 16 0.0005
537 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
538 NOCTURIA 6 0.0005
539 MUSCLE DISORDER 4 0.0005
540 DISCOMFORT 30 0.0005
541 SUBSTANCE ABUSE 4 0.0005
542 BLOOD PRESSURE INCREASED 75 0.0005
543 HYPERAESTHESIA 4 0.0005
544 HEPATIC STEATOSIS 9 0.0005
545 ACUTE CORONARY SYNDROME 4 0.0005
546 FUNGAL INFECTION 16 0.0005
547 RHABDOMYOLYSIS 20 0.0005
548 CONDITION AGGRAVATED 145 0.0005
549 ANGIOEDEMA 21 0.0005
550 BLOOD URINE PRESENT 9 0.0005
551 HEAD INJURY 15 0.0005
552 FATIGUE 368 0.0005
553 NAUSEA 373 0.0005
554 SYNCOPE 47 0.0005
555 EXPOSURE DURING PREGNANCY 29 0.0005
556 HYPERGLYCAEMIA 17 0.0005
557 HEREDITARY ANGIOEDEMA 5 0.0005
558 VOMITING 219 0.0005
559 VERTIGO 28 0.0005
560 PRODUCT DISPENSING ERROR 10 0.0005
561 PULMONARY THROMBOSIS 5 0.0005
562 FLATULENCE 26 0.0005
563 NEPHROLITHIASIS 21 0.0005
564 FALL 152 0.0005
565 ASPIRATION 5 0.0005
566 DYSGRAPHIA 3 0.0005
567 DERMATITIS ATOPIC 24 0.0005
568 GYNAECOMASTIA 14 0.0005
569 GAIT INABILITY 15 0.0004
570 GALLBLADDER DISORDER 8 0.0004
571 FACIAL PAIN 4 0.0004
572 QUALITY OF LIFE DECREASED 6 0.0004
573 OCULAR DISCOMFORT 5 0.0004
574 THERAPEUTIC RESPONSE DECREASED 27 0.0004
575 PRODUCT ADMINISTRATION ERROR 9 0.0004
576 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
577 VISUAL IMPAIRMENT 55 0.0004
578 THROAT TIGHTNESS 12 0.0004
579 OROPHARYNGEAL DISCOMFORT 4 0.0004
580 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
581 SCIATICA 7 0.0004
582 PRODUCT DOSE OMISSION ISSUE 129 0.0004
583 HIDRADENITIS 4 0.0004
584 BLOOD TESTOSTERONE DECREASED 3 0.0004
585 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
586 SENSORY DISTURBANCE 7 0.0004
587 NERVE COMPRESSION 4 0.0004
588 PRODUCT DISTRIBUTION ISSUE 4 0.0004
589 DRUG INEFFECTIVE 566 0.0004
590 GAIT DISTURBANCE 82 0.0004
591 PHOTOSENSITIVITY REACTION 7 0.0004
592 PAIN IN JAW 12 0.0004
593 DIPLOPIA 11 0.0004
594 SPINAL DISORDER 4 0.0004
595 FEAR OF INJECTION 3 0.0004
596 PRODUCT PRESCRIBING ERROR 10 0.0004
597 IRRITABLE BOWEL SYNDROME 9 0.0004
598 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
599 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
600 CONTUSION 40 0.0004
601 PRESCRIBED OVERDOSE 8 0.0004
602 CHOKING 8 0.0004
603 SKIN FISSURES 8 0.0004
604 DYSPEPSIA 40 0.0004
605 LIGAMENT SPRAIN 4 0.0004
606 CATARACT 24 0.0004
607 CYST 5 0.0004
608 ORAL PAIN 9 0.0004
609 SPINAL FRACTURE 8 0.0004
610 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
611 DERMATITIS ALLERGIC 5 0.0004
612 COLD SWEAT 7 0.0004
613 PARAESTHESIA 62 0.0004
614 DEMENTIA 11 0.0004
615 BODY TEMPERATURE INCREASED 8 0.0004
616 LIPASE INCREASED 3 0.0004
617 FEELING HOT 24 0.0004
618 PRODUCT USE ISSUE 73 0.0004
619 INFUSION SITE PAIN 5 0.0004
620 TOOTHACHE 7 0.0004
621 PRODUCT DOSE OMISSION 25 0.0004
622 FOETAL EXPOSURE DURING PREGNANCY 31 0.0004
623 ASTHMA 43 0.0004
624 THERAPY NON-RESPONDER 17 0.0004
625 ADVERSE REACTION 5 0.0004
626 GINGIVAL PAIN 3 0.0004
627 MOBILITY DECREASED 27 0.0004
628 EAR INFECTION 10 0.0004
629 RETCHING 8 0.0004
630 ABDOMINAL PAIN UPPER 77 0.0004
631 MYALGIA 63 0.0004
632 WEIGHT DECREASED 103 0.0004
633 SWELLING FACE 24 0.0004
634 PRODUCT PRESCRIBING ISSUE 8 0.0004
635 LIVER INJURY 9 0.0004
636 GASTROINTESTINAL PAIN 4 0.0004
637 DRUG LEVEL INCREASED 6 0.0004
638 HYPERTENSIVE CRISIS 4 0.0004
639 HAEMORRHOIDS 7 0.0004
640 APHONIA 5 0.0004
641 DRUG USE DISORDER 3 0.0004
642 CANDIDA INFECTION 6 0.0004
643 DIABETES MELLITUS 27 0.0004
644 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
645 CARDIAC ARREST 29 0.0004
646 DERMATITIS CONTACT 4 0.0004
647 CARDIAC OPERATION 3 0.0003
648 MUSCULOSKELETAL DISCOMFORT 6 0.0003
649 PARAESTHESIA ORAL 5 0.0003
650 TASTE DISORDER 7 0.0003
651 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
652 PERIPHERAL SWELLING 53 0.0003
653 ANAPHYLACTIC REACTION 19 0.0003
654 BLOOD CHOLESTEROL INCREASED 16 0.0003
655 SINUSITIS 35 0.0003
656 GRIP STRENGTH DECREASED 3 0.0003
657 DRY EYE 17 0.0003
658 NECK PAIN 19 0.0003
659 HEADACHE 213 0.0003
660 DEHYDRATION 45 0.0003
661 ATAXIA 4 0.0003
662 COVID-19 59 0.0003
663 MENSTRUATION IRREGULAR 9 0.0003
664 FOREIGN BODY IN REPRODUCTIVE TRACT 3 0.0003
665 GASTROINTESTINAL DISORDER 30 0.0003
666 EYE DISORDER 11 0.0003
667 POLYNEUROPATHY 4 0.0003
668 WRIST FRACTURE 4 0.0003
669 BLOOD PRESSURE FLUCTUATION 8 0.0003
670 CHILLS 39 0.0003
671 MOUTH ULCERATION 7 0.0003
672 COMPLICATION OF DEVICE REMOVAL 6 0.0003
673 HYPOAESTHESIA ORAL 5 0.0003
674 EXPIRED PRODUCT ADMINISTERED 11 0.0003
675 BONE DISORDER 6 0.0003
676 PRESYNCOPE 8 0.0003
677 NEURALGIA 8 0.0003
678 URINARY TRACT INFECTION 56 0.0003
679 JOINT INJURY 7 0.0003
680 RASH 142 0.0003
681 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
682 SMALL INTESTINAL OBSTRUCTION 4 0.0003
683 INJECTION SITE MASS 12 0.0003
684 OVERDOSE 70 0.0003
685 ASTHENIA 122 0.0003
686 THYROID DISORDER 5 0.0003
687 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
688 CHEST PAIN 60 0.0003
689 BLOOD GLUCOSE INCREASED 61 0.0003
690 MUSCULOSKELETAL CHEST PAIN 5 0.0003
691 AGRANULOCYTOSIS 6 0.0003
692 MALAISE 141 0.0003
693 TOOTH EXTRACTION 4 0.0003
694 BASAL CELL CARCINOMA 5 0.0003
695 OXYGEN SATURATION DECREASED 18 0.0003
696 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
697 SECRETION DISCHARGE 4 0.0003
698 NEUTROPHIL COUNT DECREASED 13 0.0003
699 ABORTION INDUCED 3 0.0003
700 HOT FLUSH 24 0.0003
701 BLOOD SODIUM DECREASED 6 0.0003
702 ABDOMINAL DISTENSION 33 0.0003
703 HAEMATEMESIS 8 0.0003
704 HEART RATE DECREASED 11 0.0003
705 GLOSSODYNIA 7 0.0003
706 RASH PAPULAR 7 0.0003
707 LOWER LIMB FRACTURE 6 0.0003
708 HYPERTENSION 66 0.0003
709 UNRESPONSIVE TO STIMULI 8 0.0003
710 HEART RATE IRREGULAR 7 0.0003
711 INJECTION SITE INDURATION 4 0.0003
712 BACK DISORDER 5 0.0003
713 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
714 COELIAC DISEASE 3 0.0003
715 KIDNEY INFECTION 6 0.0003
716 BEDRIDDEN 4 0.0003
717 HYPOTENSION 61 0.0003
718 OEDEMA PERIPHERAL 37 0.0003
719 ACNE 23 0.0003
720 STAPHYLOCOCCAL INFECTION 10 0.0003
721 RENAL DISORDER 14 0.0003
722 DYSURIA 11 0.0003
723 PAIN IN EXTREMITY 88 0.0003
724 LACRIMATION INCREASED 9 0.0003
725 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
726 INFLUENZA 33 0.0003
727 RASH PRURITIC 16 0.0003
728 ARTHRITIS 23 0.0003
729 EAR DISCOMFORT 3 0.0003
730 DIABETIC KETOACIDOSIS 7 0.0003
731 TREATMENT FAILURE 24 0.0003
732 EMOTIONAL DISTRESS 35 0.0003
733 DERMATITIS 6 0.0003
734 FOLLICULITIS 3 0.0003
735 INJURY 20 0.0003
736 SKIN REACTION 4 0.0003
737 BRONCHITIS 21 0.0003
738 CHEST DISCOMFORT 29 0.0003
739 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
740 BREAST PAIN 3 0.0003
741 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
742 DECREASED APPETITE 65 0.0003
743 BACK PAIN 65 0.0003
744 ABDOMINAL PAIN LOWER 7 0.0003
745 MENSTRUATION DELAYED 3 0.0003
746 OEDEMA 15 0.0003
747 HYPERTHYROIDISM 4 0.0003
748 DYSPNOEA 156 0.0003
749 LIVER FUNCTION TEST ABNORMAL 8 0.0003
750 BLOOD GLUCOSE FLUCTUATION 3 0.0003
751 ADVERSE EVENT 25 0.0003
752 BLOOD PRESSURE DECREASED 18 0.0003
753 BLOOD GLUCOSE DECREASED 13 0.0003
754 BLINDNESS 11 0.0003
755 TOOTH DISORDER 6 0.0003
756 URTICARIA 45 0.0003
757 MALNUTRITION 3 0.0003
758 PSORIASIS 35 0.0003
759 EYE PRURITUS 9 0.0003
760 PANCREATITIS ACUTE 6 0.0003
761 GASTRITIS 7 0.0003
762 PREMATURE BABY 8 0.0003
763 EYE INFECTION 3 0.0003
764 HEPATIC FAILURE 8 0.0003
765 ALOPECIA 52 0.0003
766 OSTEOPENIA 4 0.0003
767 ABDOMINAL DISCOMFORT 44 0.0003
768 HIP ARTHROPLASTY 4 0.0003
769 SKIN EXFOLIATION 22 0.0003
770 DRUG PRESCRIBING ERROR 5 0.0003
771 CEREBROVASCULAR ACCIDENT 44 0.0003
772 GLAUCOMA 5 0.0003
773 ANKLE FRACTURE 4 0.0003
774 ELECTROLYTE IMBALANCE 3 0.0003
775 PRURITUS 99 0.0003
776 DYSPHONIA 15 0.0003
777 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
778 NERVOUS SYSTEM DISORDER 8 0.0003
779 FLUID RETENTION 13 0.0003
780 NASAL CONGESTION 15 0.0003
781 BLOOD IRON DECREASED 3 0.0003
782 DIARRHOEA 163 0.0003
783 SINUS DISORDER 5 0.0003
784 PROCEDURAL PAIN 7 0.0003
785 NEUROPATHY PERIPHERAL 24 0.0003
786 FEELING COLD 7 0.0003
787 CEREBRAL HAEMORRHAGE 9 0.0003
788 CYSTITIS 8 0.0003
789 HYPERLIPIDAEMIA 3 0.0003
790 UPPER LIMB FRACTURE 5 0.0003
791 PAIN 153 0.0002
792 LOCALISED INFECTION 6 0.0002
793 C-REACTIVE PROTEIN INCREASED 9 0.0002
794 ADRENAL INSUFFICIENCY 3 0.0002
795 ARTHRALGIA 102 0.0002
796 THROAT IRRITATION 11 0.0002
797 PRODUCT PREPARATION ERROR 5 0.0002
798 EYE SWELLING 9 0.0002
799 DRUG ABUSE 20 0.0002
800 INJECTION SITE DISCOLOURATION 3 0.0002
801 SKIN DISORDER 8 0.0002
802 SKIN DISCOLOURATION 11 0.0002
803 DYSPNOEA EXERTIONAL 9 0.0002
804 INTESTINAL OBSTRUCTION 9 0.0002
805 TOXICITY TO VARIOUS AGENTS 40 0.0002
806 HYPOPHAGIA 6 0.0002
807 ARTHROPATHY 13 0.0002
808 SCAR 4 0.0002
809 SKIN ULCER 6 0.0002
810 RHINORRHOEA 15 0.0002
811 HIATUS HERNIA 3 0.0002
812 HYPERSENSITIVITY 43 0.0002
813 STOMATITIS 14 0.0002
814 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
815 BURNING SENSATION 16 0.0002
816 INJECTION SITE RASH 7 0.0002
817 HYPERKALAEMIA 8 0.0002
818 HYPOXIA 8 0.0002
819 PANCREATITIS 12 0.0002
820 HYPOGLYCAEMIA 11 0.0002
821 DYSMENORRHOEA 3 0.0002
822 HERPES ZOSTER 13 0.0002
823 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
824 BONE PAIN 13 0.0002
825 DEVICE BREAKAGE 9 0.0002
826 OSTEOPOROSIS 9 0.0002
827 CONJUNCTIVITIS 4 0.0002
828 HYPOMAGNESAEMIA 3 0.0002
829 HAEMOPTYSIS 6 0.0002
830 COUGH 60 0.0002
831 CHOLELITHIASIS 7 0.0002
832 ABDOMINAL PAIN 49 0.0002
833 CHRONIC KIDNEY DISEASE 16 0.0002
834 GASTRIC ULCER 4 0.0002
835 VIRAL INFECTION 7 0.0002
836 INCORRECT DOSE ADMINISTERED 48 0.0002
837 DISEASE RECURRENCE 10 0.0002
838 ECZEMA 11 0.0002
839 NEOPLASM MALIGNANT 14 0.0002
840 RASH ERYTHEMATOUS 10 0.0002
841 MULTIPLE SCLEROSIS 10 0.0002
842 ACUTE RESPIRATORY FAILURE 4 0.0002
843 NEEDLE ISSUE 6 0.0002
844 LABORATORY TEST ABNORMAL 6 0.0002
845 SWELLING 19 0.0002
846 CARDIOMYOPATHY 3 0.0002
847 LIVER DISORDER 9 0.0002
848 HAEMATOCRIT DECREASED 4 0.0002
849 IMMUNODEFICIENCY 3 0.0002
850 BLOOD PRESSURE ABNORMAL 4 0.0002
851 COMPLICATION OF DEVICE INSERTION 4 0.0002
852 ABORTION SPONTANEOUS 8 0.0002
853 PRODUCT PHYSICAL ISSUE 4 0.0002
854 LYMPHADENOPATHY 7 0.0002
855 EXTRA DOSE ADMINISTERED 8 0.0002
856 FLUSHING 20 0.0002
857 HYPOKALAEMIA 9 0.0002
858 EYE PAIN 11 0.0002
859 INJECTION SITE WARMTH 4 0.0002
860 INFLUENZA LIKE ILLNESS 16 0.0002
861 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
862 HAEMATOMA 5 0.0002
863 EXPOSURE VIA SKIN CONTACT 5 0.0002
864 CARDIO-RESPIRATORY ARREST 8 0.0002
865 DEAFNESS 5 0.0002
866 PYREXIA 66 0.0002
867 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
868 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
869 HIP FRACTURE 6 0.0002
870 SKIN CANCER 4 0.0002
871 PNEUMONIA 60 0.0002
872 COLITIS 7 0.0002
873 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
874 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
875 NEUTROPENIA 25 0.0002
876 BLOOD CREATININE INCREASED 12 0.0002
877 PALLOR 5 0.0002
878 CARDIAC DISORDER 17 0.0002
879 ILL-DEFINED DISORDER 11 0.0002
880 COAGULOPATHY 3 0.0002
881 DRY SKIN 24 0.0002
882 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
883 CELLULITIS 9 0.0002
884 CHROMATURIA 4 0.0002
885 HEMIPARESIS 3 0.0002
886 RED BLOOD CELL COUNT DECREASED 5 0.0002
887 GASTRIC DISORDER 6 0.0002
888 NASOPHARYNGITIS 32 0.0002
889 OROPHARYNGEAL PAIN 16 0.0002
890 INFECTION 25 0.0002
891 MUSCULOSKELETAL PAIN 9 0.0002
892 ARRHYTHMIA 8 0.0002
893 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
894 PULMONARY EMBOLISM 16 0.0002
895 COMA 8 0.0002
896 GOUT 3 0.0002
897 RESPIRATORY DISORDER 5 0.0002
898 LEUKOCYTOSIS 3 0.0002
899 ACCIDENTAL OVERDOSE 6 0.0002
900 INJECTION SITE PAIN 50 0.0002
901 HYPOACUSIS 7 0.0002
902 FEMUR FRACTURE 5 0.0002
903 SEPSIS 18 0.0002
904 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
905 EPISTAXIS 12 0.0002
906 BLISTER 9 0.0002
907 PRODUCT STORAGE ERROR 14 0.0002
908 INJECTION SITE REACTION 11 0.0002
909 ACUTE KIDNEY INJURY 24 0.0002
910 INJECTION SITE SWELLING 12 0.0002
911 ERUCTATION 3 0.0002
912 EAR PAIN 3 0.0002
913 DEVICE EXPULSION 10 0.0002
914 DEEP VEIN THROMBOSIS 10 0.0002
915 RESPIRATORY TRACT INFECTION 4 0.0002
916 OSTEONECROSIS 5 0.0002
917 BRADYCARDIA 8 0.0002
918 LIP SWELLING 5 0.0001
919 THROMBOSIS 12 0.0001
920 JAUNDICE 4 0.0001
921 PAIN OF SKIN 4 0.0001
922 DIVERTICULITIS 4 0.0001
923 WOUND 4 0.0001
924 HYPONATRAEMIA 8 0.0001
925 OSTEOARTHRITIS 6 0.0001
926 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
927 DEVICE LEAKAGE 6 0.0001
928 FAECES DISCOLOURED 3 0.0001
929 VAGINAL HAEMORRHAGE 6 0.0001
930 UNDERDOSE 10 0.0001
931 DEATH 118 0.0001
932 DRUG WITHDRAWAL SYNDROME 12 0.0001
933 RENAL FAILURE 18 0.0001
934 WHEEZING 8 0.0001
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
936 ATRIAL FIBRILLATION 13 0.0001
937 JOINT SWELLING 16 0.0001
938 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
939 NO ADVERSE EVENT 23 0.0001
940 OCULAR HYPERAEMIA 6 0.0001
941 HYPOTHYROIDISM 4 0.0001
942 PSORIATIC ARTHROPATHY 5 0.0001
943 INJECTION SITE URTICARIA 3 0.0001
944 EYE IRRITATION 7 0.0001
945 INFLAMMATION 6 0.0001
946 MYOCARDIAL INFARCTION 20 0.0001
947 RASH MACULAR 4 0.0001
948 INJECTION SITE ERYTHEMA 14 0.0001
949 INJECTION SITE BRUISING 9 0.0001
950 DEVICE ISSUE 10 0.0001
951 FREQUENT BOWEL MOVEMENTS 3 0.0001
952 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
953 DRUG EFFECT INCOMPLETE 4 0.0001
954 RHEUMATOID ARTHRITIS 12 0.0001
955 PRODUCTIVE COUGH 5 0.0001
956 ANGINA PECTORIS 3 0.0001
957 INJECTION SITE PRURITUS 7 0.0001
958 DRUG DOSE OMISSION 17 0.0001
959 LEUKOPENIA 5 0.0001
960 CORONARY ARTERY DISEASE 3 0.0001
961 HAEMOGLOBIN DECREASED 10 0.0001
962 DYSGEUSIA 7 0.0001
963 PLATELET COUNT DECREASED 10 0.0001
964 DRUG DEPENDENCE 15 0.0001
965 DEVICE DISLOCATION 4 0.0001
966 HAEMATOCHEZIA 5 0.0001
967 INFUSION RELATED REACTION 6 0.0001
968 MEDICATION ERROR 5 0.0001
969 COLITIS ULCERATIVE 4 0.0001
970 DRUG DOSE OMISSION BY DEVICE 7 0.0001
971 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
972 HAEMATURIA 3 0.0001
973 ERYTHEMA 18 0.0001
974 PRODUCT SUBSTITUTION ISSUE 5 0.0001
975 DEVICE USE ERROR 3 0.0001
976 HEPATIC FUNCTION ABNORMAL 3 0.0001
977 CARDIAC FAILURE CONGESTIVE 6 0.0001
978 ANAEMIA 14 0.0001
979 THROMBOCYTOPENIA 8 0.0001
980 SKIN BURNING SENSATION 5 0.0001
981 RESPIRATORY FAILURE 5 0.0001
982 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
983 LUNG DISORDER 3 0.0001
984 DEVICE DIFFICULT TO USE 4 0.0001
985 DISEASE PROGRESSION 7 0.0001
986 RENAL IMPAIRMENT 4 0.0000
987 HAEMORRHAGE 4 0.0000
988 INJECTION SITE HAEMORRHAGE 3 0.0000
989 CARDIAC FAILURE 3 0.0000
990 PRODUCT QUALITY ISSUE 5 0.0000
991 GASTROINTESTINAL HAEMORRHAGE 3 0.0000